Fresenius Medical Care acquires stake in Sandor Nephro Services

By: |
September 04, 2016 3:33 PM

The acquisition will help the brand create the largest international dialysis chain spread across India Fresenius Medical Care, dialysis products and services provider, has acquired 85 per cent of equity interest in Indian dialysis group Sandor Nephro Services from a group of investors. The acquisition provides an opportunity to blend the global expertise of Fresenius […]

The acquisition will help the brand create the largest international dialysis chain spread across India

Fresenius Medical Care, dialysis products and services provider, has acquired 85 per cent of equity interest in Indian dialysis group Sandor Nephro Services from a group of investors. The acquisition provides an opportunity to blend the global expertise of Fresenius Medical Care and the unique domestic business model of Sparsh which will help the brand create the largest international dialysis chain spread across India. The new entity will operate under the ‘Nephrocare‘brand of Fresenius Medical Care.

Sandor Nephro Services is expected to generate revenue of around $3 million in full year 2016. Fresenius Medical Care expects the investment to be accretive in 2017 on earnings after tax.

FMC India via its NephroCare Service entities aim to be an active long-term partner for the patients, healthcare professionals and the government in order to elevate the dialysis care in India.

Jan Walter, Senior Vice President – Central Asia Pacific, Fresenius Medical Care, said, “We are positive with the initiatives taken by the Indian government to address the unmet needs of dialysis patients all over India. We are committed to be a partner to the government to make high-quality dialysis treatments available to chronically ill dialysis patients.”

Punit Kohli, Managing Director India, Fresenius Medical Care said “We are targeting to become the largest pan-India dialysis provider through continuous expansion in Tier II and III geographies and tie-up with corporate chains and Tier I hospitals. Fresenius Medical Care will also establish ‘Centres of Excellence’ by partnering with leading medical institutions to offer and showcase state-of-the-art dialysis standards and technology. This acquisition will provide us with the necessary economies of scale to justify investments in manufacturing under the ‘Make in India’ initiative.”

“After building up one of the most successful dialysis chains in India, we now have a strong partner on our side to further grow the business”, said Saurav Panda who co-founded Sandor Nephro Services together with Gaurav Porwal.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.